NCT03726021 2023-03-29
Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Qingdao Central Hospital
Phase 2 Completed
Clinical Trials
3 trialsNCT05218629 2023-03-29
Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer
Qingdao Central Hospital
Phase 2 Unknown
NCT03275376 2021-03-16
Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 2 Terminated